ARCT
NASDAQ · Biotechnology
Arcturus Therapeutics Holdin
$7.57
+0.55 (+7.83%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+248.9% upside
Low Target
$16.23
Average Target
$26.41
High Target
$33.18
Current Price
$7.57
Current
$7.57
$7.57
Target
$26.41
$26.41
$16.23
$26.41 avg
$33.18
Scenario Analysis
Bear Case
$16.23
114.4%
Low target
Base Case
$26.41
+248.9%
Avg target
Bull Case
$33.18
+338.3%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$27.70
-72.7% from high
52-Week Low
$18.44
+-58.9% from low
Target vs 52W High
$26.41
-4.7% vs high
Next Earnings Report
Mar 2, 2026 · After Market Close
13d
until earnings
EPS Est: $-0.73
Earnings in 13 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |